Our patient and LNCaP xenograft data confirmed that androgen receptor regulation of ASCT2 contributes to its expression in untreated/primary cancer and that under androgen‐deprivation therapy, ASCT2 levels decrease. The gene discussed is SLC1A5; the disease is cancer.